fbpx

< Back to Thought Leadership

Additional Manufacturers Seek Contract Pharmacy Data and Place Restrictions on 340B Programs

AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their own on-site dispensing pharmacies.” Eli Lilly had previously stated it would provide Cialis at 340B pricing to only one contract pharmacy location for each entity. Both companies appear to be challenging 2010 guidance from HRSA.

Contract pharmacies in the 340B Program were created in 1996, four years after 340B itself. The 1996 guidance from HRSA “permitted a covered entity to use a single point for pharmacy services, either an in-house pharmacy or an individual contract pharmacy”. In 2010, additional guidance from HRSA allowed an unlimited number of contract pharmacies. HRSA has stated its 2010 guidance is still in effect but is not enforceable unless there is a clear violation of the 340B statute.

Novartis distributed letters to covered entities recently stating it will be requesting contract pharmacy data, including Medicaid, Medicare, and commercial claims, in order to address duplicate discounts and “ineligible rebates”. These letters are in addition to previous letters from Merck and Sanofi requesting contract pharmacy data be uploaded to a portal created by Second Sight Solutions called 340B ESP.

The current 340B statue only requires covered entities to protect against duplicate discounts with Medicaid fee-for-service patients. Also, the Final 2016 Medicaid OP Drug Reimbursement Regulations indicated the States and the respective MCO companies (not the covered entities) are responsible for ensuring duplicate discounts do not occur for Medicaid Managed Care claims. CMS emphasized this requirement in an answer to a comment in the regulations. Wellpartners, the TPA for CVS contract pharmacies, provided letters to covered entities using its platform stating it will only authorize the release of Medicaid claim data to 340B ESP.

In the coming weeks, it is anticipated additional manufacturers will distribute similar letters causing more confusion and burden on covered entities.

We will continue to monitor developments and provide updates as available. If you have any questions, please reach out to one of our Apexus Certified 340B Experts.

 

2023 E/M Coding Changes You Need to Know from the Physician Fee Schedule Final Ruling

New rules for reporting evaluation and management (E/M) services in most places of service took effect January 1, 2023. The coding and documentation revisions, adopted by the American Medical Association’s CPT Editorial Panel and approved by the Centers for Medicare and Medicaid Services (CMS), substantially simplify code selection and documentation. Effective January 1st, E/M services […]

Learn More

Consolidated Appropriations Act of 2023 Changes Impacting Rural Health Clinics

The Consolidated Appropriations Act of 2023, also known as the “Omnibus” package, was signed into law by President Biden on December 29, 2022. Rural Health Clinics (RHCs) need to be aware of some of the changes that will impact them including new grant opportunities and behavioral health provisions. Opportunities for Rural Health Clinics from the […]

Learn More
someone handing car keys to another person personal use of auto

The Importance of Personal vs. Business Use of Auto

By Pam Swartout, Manager and Jacoby Shade, Staff Accountant at Blue & Co. Many business owners provide a company vehicle to their employees as part of their employment. This is a company benefit that has tax implications and is extremely important for both the employer and employee to understand these implications. Employers can deduct only […]

Learn More